Breaking News, Collaborations & Alliances

Boehringer Ingelheim Selects Veeva Development Cloud to Deliver Therapies Faster

Aims to establish a connected technology landscape for agile collaboration that can accelerate the development of novel medicines.

Author Image

By: Charlie Sternberg

Associate Editor

Boehringer Ingelheim has selected Veeva Development Cloud to drive its end-to-end processes and information sharing for greater speed in the delivery of innovative therapies.   A research-driven biopharmaceutical company, Boehringer Ingelheim, is working on breakthrough therapies that improve the lives of humans and animals and creating value through innovation in areas of high unmet medical need. By bringing together data and processes across clinical, regulatory, and quality on a single clou...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters